Cargando…

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination

Aquaporins (AQPs; AQP0–AQP12) are water channels expressed in many and diverse cell types, participating in various functions of cells, tissues, and systems, including the central nervous system (CNS). AQP dysfunction and autoimmunity to AQPs are implicated in several diseases. The best-known exampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pechlivanidou, Maria, Xenou, Konstantina, Tzanetakos, Dimitrios, Koutsos, Emmanuel, Stergiou, Christos, Andreadou, Elisabeth, Voumvourakis, Konstantinos, Giannopoulos, Sotirios, Kilidireas, Constantinos, Tüzün, Erdem, Tsivgoulis, Georgios, Tzartos, Socrates, Tzartos, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455752/ https://www.ncbi.nlm.nih.gov/pubmed/37629163 http://dx.doi.org/10.3390/ijms241612982

Ejemplares similares

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
por: Tzartos, John S., et al.
Publicado: (2020)

Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders
por: Tzartos, John S., et al.
Publicado: (2022)

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
por: Vakrakou, Aigli G., et al.
Publicado: (2021)

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Early metabolic alterations in the normal‑appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: A proton MR spectroscopic study
por: Tzanetakos, Dimitrios, et al.
Publicado: (2023)

Sexual dysfunction therapeutic approaches in patients with multiple sclerosis: a systematic review
por: Giannopapas, Vasileios, et al.
Publicado: (2022)

Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
por: Koros, Christos, et al.
Publicado: (2013)

Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
por: Koneczny, Inga, et al.
Publicado: (2021)

Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
por: Karagiorgou, Katerina, et al.
Publicado: (2022)

Delayed Leucoencephalopathy as a Complication after Endovascular Therapy of Intracranial Aneurysms—A Case Series
por: Bakola, Eleni, et al.
Publicado: (2023)

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
por: Pafiti, Anna, et al.
Publicado: (2023)

Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
por: Kazakou, Paraskevi, et al.
Publicado: (2023)

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies
por: Koneczny, Inga, et al.
Publicado: (2022)

The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis
por: Giannopapas, Vasileios, et al.
Publicado: (2023)

IL-6 Serum Levels in COVID-19 Patients With Vertigo
por: Kitsos, Dimitrios, et al.
Publicado: (2023)

Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review
por: Yiannopoulou, Konstantina, et al.
Publicado: (2023)

Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review
por: Theodorou, Aikaterini, et al.
Publicado: (2022)

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis
por: Tzanetakos, Dimitrios, et al.
Publicado: (2022)

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes
por: Vakrakou, A. G., et al.
Publicado: (2018)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
por: Stergiou, Christos, et al.
Publicado: (2023)

Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice
por: Ulusoy, Canan, et al.
Publicado: (2015)

The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts
por: Tzanetakos, D., et al.
Publicado: (2020)

Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
por: Lagoumintzis, George, et al.
Publicado: (2021)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
por: Yilmaz, Vuslat, et al.
Publicado: (2015)

Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature
por: Andreadou, E., et al.
Publicado: (2013)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
por: Karathanasis, Dimitris K., et al.
Publicado: (2022)

Capecitabine Induced Multifocal Leukoencephalopathy: Do We Have Always to Switch off the Chemotherapy?
por: Bougea, Anastasia, et al.
Publicado: (2016)

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Structural Insights into the Role of β3 nAChR Subunit in the Activation of Nicotinic Receptors
por: Giastas, Petros, et al.
Publicado: (2022)

Clinical Characteristics, Neuroimaging Markers, and Outcomes in Patients with Cerebral Amyloid Angiopathy: A Prospective Cohort Study
por: Theodorou, Aikaterini, et al.
Publicado: (2023)

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients
por: Tzartos, John S, et al.
Publicado: (2014)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Recent Advances in Genetic Predisposition of Myasthenia Gravis
por: Zagoriti, Zoi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4rck0mq14r5hlcd090tk1jfdg9